COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.
Tony Cordrey
Advertisement
Tony Cordrey is vice‑president of European Strategic Operations, Accord Healthcare.
Articles by Tony Cordrey
Advertisement
Latest Updated Articles
Reinvesting in European ManufacturingAugust 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
France Remains One of Europe’s Leading Biotech Funding Hubs
5